Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice (Q41070474)

26 September 2017

title

Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice (English)

1 reference

26 September 2017

0 references

1 reference

0 references

Di Santo E

1

1 reference

26 September 2017

Adami M

series ordinal

2

1 reference

26 September 2017

Bertorelli R

series ordinal

3

1 reference

26 September 2017

Ghezzi P

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

European Journal of Pharmacology

26 September 2017

published in

1 reference

26 September 2017

volume

336

1 reference

26 September 2017

issue

2-3

1 reference

26 September 2017

page(s)

197-202

1 reference

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Proinflammatory cytokines as pathogenetic mediators in the central nervous system: brain-periphery connections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Central administration of the peptide α-MSH inhibits inflammation in the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Production of interleukin-10 by mouse glial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Diffferential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

Differences in endogenous pyrogen fevers induced by iv and icv routes in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901225-9

10.1016/S0014-2999(97)01225-9

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference